搜索筛选:
搜索耗时0.0823秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
[期刊论文] 作者：Ke MA,Li-min YANG,Hong-zhuan CHEN,Yang LU,
来源：中国药理学报（英文版） 年份：2013
...
The metronomic chemotherapy of targeted nanoparticulate drug delivery systems results in tumor vascu
[会议论文] 作者：Xin Luan,Ying-yun Guan,Ya-rong Liu,Hong-zhuan Chen,Chao Fang,
来源：2014年中国药物制剂大会——中国药学会药剂专业委员会年会、第六届亚洲阿登制药技术研讨会暨国际控释协会中国分会年会 年份：2014
...
The metronomic chemotherapy of targeted nanoparticulate drug delivery systems results in tumor vascu
[会议论文] 作者：Xin Luan,Ying-yun Guan,Ya-rong Liu,Hong-zhuan Chen,Chao Fang,
来源：2014年中国药物制剂大会——中国药学会药剂专业委员会年会、第六届亚洲阿登制药技术研讨会暨国际控释协会中国分会年会 年份：2014
Introduction: Tumor-specific abnormalities in the microenvironment play a critical role in hampering drug treatment efficacy and contributing to drug resistance.The emerging therapeutic strategy of "t...
[期刊论文] 作者：Xing-jun WU,Yong-jun ZHENG,Yong-yao CUI,Liang ZHU,Yang LU,Hong-zhuan CHEN,
来源：中国药理学报（英文版） 年份：2007
Aim: To investigate the neuroprotective effect of propofol and its intracellular mechanism on neurons in vitro. Methods: Cell viability was determined with 3-(4...
,Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-t
[期刊论文] 作者：Hong CHEN,King-jun WU,Xi-yuan LU,Liang ZHU,Li-ping WANG,Huang-tian YANG,Hong-zhuan CHEN,Wen-jun YUAN,
来源：中国药理学报（英文版） 年份：2005
Aim: To examine the tolerance of type 1 diabetic hearts to ischemia and reperfusion injury.Myocardial contents of 27-kDa and 70-kDa heat shock proteins (hsp) as...
[期刊论文] 作者：ZHU,Li-min YANG,Yong-yao CUI,Pei-li ZHENG,Yin-yao NIU,Hao WANG,Yang LU,Qiu-shi REN,Pi-jing WEI,Hong-zhuan CHEN,
来源：中国药理学报（英文版） 年份：2008
Aim: To study the stereoselectivity of satropane (3-paramethylbenzene sulfonyloxy-6-acetoxy tropane), a novel tropane analog, on iris muscarinic receptor activa...
HKB99,an allosteric inhibitor of phosphoglycerate mutase 1,suppresses invasive pseudopodia formation
[期刊论文] 作者：Qian Liang,Wei-ming Gu,Ke Huang,Ming-yu Luo,Jing-hua Zou,Guang-lei Zhuang,Hui-min Lei,Hong-zhuan Chen,
来源：中国药理学报（英文版） 年份：2021
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors(EGFR-TKIs),such as erlotinib,remains a major challenge in the targeted therap...
相关搜索：
